CeQur SA, a company focused on the development and commercialization of insulin delivery systems to improve the management of type 2 diabetes, completed its...
Afferent Pharmaceuticals, a Palo Alto, CA-based company focused on developing compounds that treat chronic pain, closed a $23m Series A financing round.The round was...
Molecular Partners AG, a Zurich, Switzerland-based developer of protein therapeutics, has announced the closing of its CHF 46 million (€30m, $45m) Series B equity...
Covagen, a Zurich, Switzerland-based company pioneering the development of a novel class of protein therapeutics (Fynomers), announced that it secured an undisclosed amount of...
C.En Ltd., a Zurich, Switzerland-based developer of hydrogen storage technology, has completed a round of equity financing.The round was led by Generali Financial Holdings...
Cardiola AG, a Winterthur-Switzerland-based company that develops a device for treating chronic heart failure, announced today that it has raised an additional $4m...
capiton AG, a Berlin, Germany-based independent private equity firm, announced the final closing of its capiton IV fund.According to the company, the targeted fund...
Argos Soditic, an independent European private equity firm with offices in Geneva, Paris and Milan, acquired, through an MBO, a majority stake in MISAPOR,...
Biocartis SA closed its €10m ($14.9m) Series A equity financing round led by Amsterdam-based Aescap Venture with participation from a syndicate of European investors...
Investindustrial, Southern Europe’s leading private equity firm, completed the raising of its Build-Up Fund for the €500m Investindustrial III L.P. ('Fund III') at the...
